No products in the cart.
Cat:GMP-h-MMP3
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Genemedi produces core diagnostic ingredients for test of Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) and related syndrome. GeneMedi offers paired diagnostics grade matrix metalloproteinase-3 (MMP3) antibodies (monoclonal antibody, mab) and antigens for Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) rapid test kit of matrix metalloproteinase-3 (MMP3) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cardiovascular disease (cancer, asthma and
rheumatoid arthritis ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Matrix metalloproteinases (MMPs) are a large
family of proteases involved in many cell-matrix and cell-cell signalling
processes through activation, inactivation or release of extracellular matrix
(ECM) and non-ECM molecules, such as growth factors and receptors. Uncontrolled
MMP activities underlie the pathophysiology of many disorders. Also, matrix
metalloproteinase-3 (MMP-3) or stromelysin-1 contributes to several
pathologies, such as cancer, asthma and rheumatoid arthritis, and has also been
associated with neurodegenerative diseases like Alzheimer’s disease,
Parkinson’s disease and multiple sclerosis.
Product Description
Cat No. of Pruducts
GMP-h-MMP3-Ag01:Recombinant Human MMP3 Protein
Product Name
Recombinant Human MMP3 Protein
Target
matrix metalloproteinase-3
Alias of Target/Biomarker
CHDS6, MMP-3, SL-1, STMY, STMY1, STR1
Expression platform
E.coli
Isotypes
Recombinant Antigen
Bioactivity validation
matrix metalloproteinase-3 (MMP3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MMP3 level test of Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) and related syndrome evaluation
Tag
His
Products description
Recombinant Human MMP3 Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Previous slide
Next slide
Cat No. of Pruducts
GMP-h-MMP3-Ab01,GMP-h-MMP3-Ab02:Anti-Human MMP3 mouse monoclonal antibody (mAb)
Product Name
Anti-Human MMP3 mouse monoclonal antibody (mAb)
Target
Alias of Target/Biomarker
CHDS6, MMP-3, SL-1, STMY, STMY1, STR1
Expression platform
Hybridoma
Isotypes
Mouse IgG
Bioactivity validation
Human matrix metalloproteinase-3 (MMP3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other matrix metalloproteinase-3 (MMP3) antibodies in MMP3 level test of Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) and related syndrome evaluation.
Tag
mFc
Products description
Anti-Human MMP3 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other matrix metalloproteinase-3 (MMP3) antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1
Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
